Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) is pleased to offer its ordinary shareholders residing in New Zealand and Australia the option to participate in a Dividend Reinvestment Plan (DRP).
The DRP will allow eligible shareholders to elect to reinvest all or part of their cash dividends in additional Fisher & Paykel Healthcare ordinary shares.
The following documents will be despatched to eligible shareholders today in relation to the implementation of the DRP:
The first dividend that the DRP will apply to is the final dividend for the financial year ended 31 March 2009 which is payable on 6 July 2009. Participation Notices must be received by the Company’s Share Registrar by 5.00pm New Zealand time on 19 June 2009 to be effective for this final dividend.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119
Dividend Reinvestment Plan
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment